PVAI was incubated inside of Genpact to construct a flexible, verified collection of top-tier Artificial
Intelligence SaaS modules, tailored exclusively to address the various challenges present in
Pharmacovigilance (PV). These SaaS modules licences were sold to Pfizer, GSK, and Bayer and
each clients backend infrastructure and application were hosted in its own AZURE / AWS account.
JPhozin was assigned the to review (AI) and ML services, infrastructure, and implementation
resources and recommend enhancement of the ML models automation with cost optimisation
factored.
When it comes to evaluating and enhancing the infrastructure that supports your machine learning models conducting a Machine Learning Model Infrastructure Review is essential. This step is crucial, in guaranteeing the dependability, scalability and efficiency of your ML applications. Here’s a guide, on how Jphozin tackles this process;
After undergoing our comprehensive assessment of the clients machine learning infrastructure, we were able to identify and rectify existing bottlenecks, streamline processes, and unlock tremendous potential for growth. We helped to enhance (AI) and ML models infrastructure automation and drove down monthly cost by 30%. We identified issues with the immature deployment process and helped in redesigning of the deployment automation which reduced deployment of 350 environments from 2 weeks to 20mins.